Reporters have accused PBMs of steering patients toward more expensive drugs and extracting hidden fees.

Benefits advisors play a crucial role in safeguarding the health and financial wellbeing of millions of Americans, making their role more vital than ever in the face of recent significant legal and economic challenges.

Pharmacy benefit manager Optum Rx plans to launch Clear Trend Guarantee in 2025 to allow employers and health insurers to more easily manage their drug spending, while creating more predictability for patients around costs.

Eli Lilly had agreed to cap the price of insulin at $35 per month for 4 years and provide a $13.5 million cash fund, however, a dozen state attorneys general, some with their own insulin lawsuits, had objected to the settlement.